---
figid: PMC9399752__fphar-13-880589-g011
figtitle: Renshen Baidu powder protects ulcerative colitis via inhibiting the PI3K/Akt/NFKB
  signaling pathway
organisms:
- Panax ginseng
- Glycyrrhiza uralensis
- Garcinia mangostana
- Wolfiporia cocos
- Platycodon grandiflorus
- Citrus aurantium
- Bupleurum chinense
- Hansenia weberbaueriana
- Angelica biserrata
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9399752
filename: fphar-13-880589-g011.jpg
figlink: /pmc/articles/PMC9399752/figure/F11/
number: F11
caption: Major pathways of RSBDP treating UC. In a PDK1-dependent way, activated PI3K
  stimulates Akt activation. IKK is a downstream signal transduction pathway that
  can be regulated by activated Akt. The IKK complex is composed of the two catalytic
  subunits IKK-α and IKK-β and the regulatory subunit IKK-γ. The activated IKK phosphorylated
  its substrate IκB so that the NF-κB subunit p65 and p50 were transferred from cytoplasm
  to nucleus to activate NF-κB. The activated NF-κB can promote pro-inflammatory cytokines
  and increase the levels of cytokines, such as IL-6 and TNF-α. In this research,
  RSBDP can inhibit the phosphorylation of PI3K, Akt, and NF-κB while upregulating
  the NF-κB inhibitor protein IκB and downregulating the activator protein IKK, thus
  blocking the activation of the PI3K/Akt/NF-κB signaling pathway and treating UC.
papertitle: Renshen Baidu powder protects ulcerative colitis via inhibiting the PI3K/Akt/NF-κB
  signaling pathway.
reftext: Zhen Ye, et al. Front Pharmacol. 2022;13:880589.
year: '2022'
doi: 10.3389/fphar.2022.880589
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: Renshen Baidu powder | ulcerative colitis | PI3K | Akt | NF-κB | TNBS-induced
  colitis
automl_pathway: 0.9621093
figid_alias: PMC9399752__F11
figtype: Figure
redirect_from: /figures/PMC9399752__F11
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9399752__fphar-13-880589-g011.html
  '@type': Dataset
  description: Major pathways of RSBDP treating UC. In a PDK1-dependent way, activated
    PI3K stimulates Akt activation. IKK is a downstream signal transduction pathway
    that can be regulated by activated Akt. The IKK complex is composed of the two
    catalytic subunits IKK-α and IKK-β and the regulatory subunit IKK-γ. The activated
    IKK phosphorylated its substrate IκB so that the NF-κB subunit p65 and p50 were
    transferred from cytoplasm to nucleus to activate NF-κB. The activated NF-κB can
    promote pro-inflammatory cytokines and increase the levels of cytokines, such
    as IL-6 and TNF-α. In this research, RSBDP can inhibit the phosphorylation of
    PI3K, Akt, and NF-κB while upregulating the NF-κB inhibitor protein IκB and downregulating
    the activator protein IKK, thus blocking the activation of the PI3K/Akt/NF-κB
    signaling pathway and treating UC.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nfkb1
  - Syt1
  - Rel
  - Npc2
  - Pik3cg
  - Pdk1
  - Akt1
  - Tnf
  - Il1b
  - NFKB1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - REL
  - IKBKG
  - IKBKB
  - CHUK
  - IKBKE
  - TBK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - TNF
  - IL1B
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - Nfkbib
  - Ikbkb
  - Pik3r1
  - Pdpk1
  - Dif
  - dl
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - wash
  - key
  - IKKbeta
  - IKKepsilon
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - egr
---
